HER-2/neu overexpression in colonic malignancies [5] (multiple letters)

Gastroenterology

Volumn 122, Issue 1, 2002, Pages 248-249

  Gill, N ^a   Malik, A ^a   Potti, A ^a   Talukdar, R ^a   Saberi, A ^a   Mehdi, S A ^a   Slikowski, M X ^a   Du Bois, R N ^a  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SURVIVAL; CLINICAL ARTICLE; COLON CANCER; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; ONCOGENE NEU; PRIORITY JOURNAL;

EID: 0036140867     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.30917     Document Type: Article

References (4)

1. LN Klapper MH Kirschbaum M Sela Y Yarden Biochemical and clinical implications of the Erb B/HER signaling network of growth factor receptors Adv Cancer Res 77 2000 25 79
2. M Mann H Sheng J Shao CS William PI Pisacane MX Sliwkowski RN Dubois Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth Gastroenterology 120 2001 1713 1719
3. Micke P, Hengstler JG, Ros R, Bittinger F, Meta T, Gebhard S, Beeh KM, Oesch F, Buhl R. Mianz University, Mainz, Germany.
4. Willardson JD, Potti A, Langness E, Chittajallu S, Levitt R, Mehdi SA. University of North Dakota School of Medicine, Fargo, ND; Roger Maris Cancer Center, Fargo, ND.